- Contains the most current research on mucosal immunology and is comprehensive in scope- Includes ideal coverage of both the basic and clinical aspects of the mucosal immune system- Provides an understanding of the mucosal immune system with regard to new treatments and preventative methods, including vaccine development- Includes contributions from an international team of experts
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
University of Alabama, Birmingham, U.S.A. and Osaka University, Japan
Since the 1970s, Professor Kiyono has been investigating and characterizing unique features of the mucosal immune system to establish mucosal immunology as an area of the immunology field as well as to develop effective and safe mucosal vaccines against infectious diseases and mucosal immune therapies against allergic and inflammatory diseases. He recently developed cold-chain- and needle-free rice-based vaccines (MucoRice) with the cooperation of agricultural researchers. The vaccine antigens exogenously expressed in MucoRice are temperature-stable for at least 2.5 years and are resistant to digestive enzymes, thus they effectively induce vaccine antigen-specific protective immunity in both systemic and mucosal compartments against toxins produced by pathogenic microorganisms (e.g., cholera toxins). Additionally, his efforts aim to clarify the immunological cross-talk between the mucosal immune system and mucosal environmental factors (e.g., commensal bacteria and dietary materials) in immunological homeostasis. These studies will lead to the development of novel immune therapies against mucosal immune diseases, such as food allergy, rhinitis, and inflammatory bowel diseases.